E2, 4OHT, and Act D were purchased from Sigma. TNFα, IL-1β, and IL6 were obtained from R&D Systems. ICI 182,780 (ICI) was purchased from Tocris. The NFκB inhibitor, IKK7, was purchased from EMD Millipore. The PHLDA1 antibody was purchased from Santa Cruz Biotechnology (sc-23866) and the β-actin antibody from Sigma (A5441). DMA was generously provided by Dr. Gregory Thatcher (UIC). siRNA targeting ERα or PHLDA1 or a nonspecific control (siNeg) was purchased from Ambion. PHLDA1 miScript target protector for miR-181 and miR-181a and b synthetic mimics were purchased from Qiagen. Anti-miR-181a and b inhibitors were purchased from Ambion.
Phlda1 miscript target protector for mir 181
Manufactured by Qiagen
The PHLDA1 miScript target protector for miR-181 is a laboratory tool designed to inhibit the binding of miR-181 to the PHLDA1 target. It functions by binding to the miR-181 binding site on the PHLDA1 mRNA, preventing the interaction between miR-181 and its target.
Automatically generated - may contain errors
Lab products found in correlation
Ici 182 780, by Bio-Techne (2 mentions)
Sineg, by Thermo Fisher Scientific (2 mentions)
Sirna targeting, by Thermo Fisher Scientific (2 mentions)
Mir 181a and b synthetic mimics, by Qiagen (2 mentions)
Anti mir 181a and b inhibitors, by Thermo Fisher Scientific (2 mentions)
4 oht, by Merck Group (2 mentions)
β actin antibody, by Merck Group (2 mentions)
Il 1β, by R&D Systems (2 mentions)
Tnf α, by R&D Systems (2 mentions)
Interleukin 6 (il 6), by R&D Systems (2 mentions)
2 protocols using phlda1 miscript target protector for mir 181
1
Molecular Regulation of PHLDA1 Expression
2
Molecular Regulation of PHLDA1 Expression
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
E2, 4OHT, and Act D were purchased from Sigma. TNFα, IL-1β, and IL6 were obtained from R&D Systems. ICI 182,780 (ICI) was purchased from Tocris. The NFκB inhibitor, IKK7, was purchased from EMD Millipore. The PHLDA1 antibody was purchased from Santa Cruz Biotechnology (sc-23866) and the β-actin antibody from Sigma (A5441). DMA was generously provided by Dr. Gregory Thatcher (UIC). siRNA targeting ERα or PHLDA1 or a nonspecific control (siNeg) was purchased from Ambion. PHLDA1 miScript target protector for miR-181 and miR-181a and b synthetic mimics were purchased from Qiagen. Anti-miR-181a and b inhibitors were purchased from Ambion.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!